Ftse Mib
34.460,96
-1,05%
DAX
18.695,16
-0,38%
S&P 500
5.308,13
0,09%
NASDAQ
16.794,87
0,65%
Bitcoin
70.977,71
-0,66%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cynapsus Therapeutics Inc. (MM) (CYNA) Cynapsus Therapeutics Inc. (MM) (CYNA) Notizie

CYNA

Cynapsus Therapeutics Inc. (CYNA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CYNA
DataOraFonteTitoloSimboloCompagnia
04/05/202214:05Business WireCyngn Launches Infinitracker – A GPS Asset Tracker and IoT Gateway with 15-year BatteryNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
02/05/202214:05Business WireCyngn Schedules 2022 First Quarter Financial Results Release and Conference CallNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
29/04/202222:20Business WireCyngn Announces Closing of $20 Million Private Placement Priced At-the-MarketNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
28/04/202215:15Business WireCyngn Announces Pricing of $20 Million Private Placement Priced At-the-MarketNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
21/04/202214:30Business WireCyngn Launches DriveMod Kit, a Fully-Equipped Autonomous Vehicle Hardware Integration ModuleNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
23/03/202221:05Business WireCyngn Reports Fourth Quarter and Year-end 2021 ResultsNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
14/03/202213:05Business WireCyngn Schedules 2021 Fourth Quarter and Year-End Financial Results Release and Conference CallNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
23/02/202214:05Business WireCyngn to Present at the Cowen 2nd Annual Mobility Disruption ConferenceNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
15/02/202214:05Business WireCyngn Files Patent for DriveMod Kit, an Adaptive, Turnkey Autonomous Vehicle SolutionNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
10/02/202214:05Business WireCyngn to Present at the Aegis Virtual ConferenceNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
03/02/202214:00Business WireGreenland Technologies Chooses Cyngn to Bring Autonomous Vehicle Technology to Their Fleet of Lithium-Powered Electric ForkliftsNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
24/01/202214:05Business WireCyngn Announces Appointment of HR Veteran Marc Brown as Vice President of Human ResourcesNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
18/01/202214:05Business Wire Cyngn and Columbia Vehicle Group to Begin Building Fleet of Autonomous Industrial VehiclesNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
10/01/202214:05Business WireGlobal Logistics & Fulfillment Taps Cyngn to Bring Autonomous Vehicle Capabilities to its Fulfillment CentersNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
08/12/202114:05Business WireCyngn to Provide an Insider’s Look into the Company’s Technology Stack in its First Webinar on December 15, 2021NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
17/11/202122:05Business WireCyngn Reports Third Quarter 2021 ResultsNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
09/11/202114:30Business WireCyngn Schedules 2021 Third Quarter Financial Results Release and Conference CallNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
22/10/202118:10Business WireCyngn Announces Closing of Initial Public OfferingNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
19/10/202123:31Business WireCyngn Announces Pricing of Initial Public OfferingNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
17/03/202021:23Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
15/02/201713:09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
01/11/201618:25Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
24/10/201623:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
21/10/201623:14Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
21/10/201623:14Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
21/10/201615:22Edgar (US Regulatory)(25-NSE)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
18/10/201615:08GlobeNewswire Inc.Cynapsus Therapeutics Obtains Final Court Order and HSR Waiting Period Expires for Plan of Arrangement with Sunovion Pharmace...NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
13/10/201622:00GlobeNewswire Inc.Cynapsus Therapeutics Securityholders Approve the Plan of Arrangement with Sunovion PharmaceuticalsNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
29/09/201601:27GlobeNewswire Inc.ISS Recommends Cynapsus Therapeutics Securityholders Vote for the Plan of ArrangementNASDAQ:CYNACynapsus Therapeutics Inc. (MM)
12/09/201622:08Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CYNACynapsus Therapeutics Inc. (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CYNA

La tua Cronologia

BINA
MAGICUSDT
MAGIC
ASX
CSF
Catalano Seafood
UPBT
ETCBTC
Ethereum Classic
KUCN
PRMXUSDT
PREMA
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network